Justin G. Julander, Ph.D. - Publications

2005 Utah State University, Logan, UT, United States 
Microbiology Biology, Veterinary Science Biology

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Julander JG, Bunyan E, Jordan R, Porter DP. Remdesivir efficacy against yellow fever in a hamster model. Antiviral Research. 105331. PMID 35533777 DOI: 10.1016/j.antiviral.2022.105331  0.496
2022 Doyle MP, Genualdi JR, Bailey AL, Kose N, Gainza C, Rodriguez J, Reeder KM, Nelson CA, Jethva PN, Sutton RE, Bombardi RG, Gross ML, Julander JG, Fremont DH, Diamond MS, et al. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. Mbio. e0051222. PMID 35420472 DOI: 10.1128/mbio.00512-22  0.408
2022 Julander JG, Anderson N, Haese N, Andoh T, Streblow DN, Cortez P, Carter K, Marniquet X, Watson H, Mandron M. Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease. Antiviral Research. 105295. PMID 35339583 DOI: 10.1016/j.antiviral.2022.105295  0.511
2022 Lin K, Good SS, Julander JG, Weight AE, Moussa A, Sommadossi JP. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model. Plos Neglected Tropical Diseases. 16: e0009937. PMID 35073319 DOI: 10.1371/journal.pntd.0009937  0.523
2021 Julander JG, Demarest JF, Taylor R, Gowen BB, Walling DM, Mathis A, Babu YS. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Research. 195: 105180. PMID 34551346 DOI: 10.1016/j.antiviral.2021.105180  0.397
2021 Good SS, Shannon A, Lin K, Moussa A, Julander JG, La Colla P, Collu G, Canard B, Sommadossi JP. Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with and activity against dengue and other flaviviruses. Antimicrobial Agents and Chemotherapy. AAC0098821. PMID 34424050 DOI: 10.1128/AAC.00988-21  0.478
2021 Williamson LE, Reeder KM, Bailey K, Tran MH, Roy V, Fouch ME, Kose N, Trivette A, Nargi RS, Winkler ES, Kim AS, Gainza C, Rodriguez J, Armstrong E, Sutton RE, ... ... Julander JG, et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 184: 4430-4446.e22. PMID 34416147 DOI: 10.1016/j.cell.2021.07.033  0.324
2021 Vang L, Morello CS, Mendy J, Thompson D, Manayani D, Guenther B, Julander J, Sanford D, Jain A, Patel A, Shabram P, Smith J, Alexander J. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus. Plos Neglected Tropical Diseases. 15: e0009195. PMID 33711018 DOI: 10.1371/journal.pntd.0009195  0.411
2020 Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, et al. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Viruses. 12. PMID 33291455 DOI: 10.3390/v12121394  0.348
2020 Julander JG, Dagley A, Gebre M, Komeno T, Nakajima N, Smee DF, Furuta Y. Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus. Antiviral Research. 182: 104904. PMID 32791074 DOI: 10.1016/J.Antiviral.2020.104904  0.595
2020 Liang B, Yuan X, Wei G, Wang W, Zhang M, Peng H, Javer A, Mendenhall M, Julander J, Huang S, Michail H, Lu Y, Zhu Q, Baldwin J. Toxicity Studies and Inactivation of SARS-CoV-2 by Povidone-iodine Gel Forming Formulations. Biorxiv : the Preprint Server For Biology. PMID 32511395 DOI: 10.1101/2020.05.18.103184  0.376
2020 Yun SI, Song BH, Woolley ME, Frank JC, Julander JG, Lee YM. Development, Characterization, and Application of Two Reporter-Expressing Recombinant Zika Viruses. Viruses. 12. PMID 32456014 DOI: 10.3390/V12050572  0.457
2020 Zarai Y, Zafrir Z, Siridechadilok B, Suphatrakul A, Ruppin M, Julander J, Tuller T. Evolutionary Selection against Short Nucleotide Sequences in Viruses and their Related Hosts. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. PMID 32339222 DOI: 10.1093/Dnares/Dsaa008  0.408
2020 Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses. Antiviral Research. 176: 104749. PMID 32081740 DOI: 10.1016/J.Antiviral.2020.104749  0.513
2019 Clancy CS, Van Wettere AJ, Morrey JD, Julander JG. Zika Virus Associated Pathology and Antigen Presence in the Testicle in the Absence of Sexual Transmission During Subacute to Chronic Infection in a Mouse Model. Scientific Reports. 9: 8325. PMID 31171800 DOI: 10.1038/S41598-019-44582-9  0.686
2019 Jonsson CB, Cao X, Lee J, Gabbard JD, Chu YK, Fitzpatrick EA, Julander J, Chung DH, Stabenow J, Golden JE. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses. Antiviral Research. PMID 30970271 DOI: 10.1016/J.Antiviral.2019.04.004  0.528
2019 Siddharthan V, Miao J, Van Wettere AJ, Li R, Wu H, Sullivan E, Jiao J, Hooper JW, Safronetz D, Morrey JD, Julander JG, Wang Z. Human Polyclonal Antibodies Produced from Transchromosomal Bovine Provides Prophylactic and Therapeutic Protections Against Zika Virus Infection in KO Syrian Hamsters. Viruses. 11. PMID 30678320 DOI: 10.3390/V11020092  0.694
2018 Clancy CS, Van Wettere AJ, Morrey JD, Julander JG. Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model. Scientific Reports. 8: 15379. PMID 30337585 DOI: 10.1038/S41598-018-33528-2  0.673
2018 Julander JG, Testori M, Cheminay C, Volkmann A. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model. Frontiers in Immunology. 9: 1756. PMID 30116244 DOI: 10.3389/Fimmu.2018.01756  0.354
2018 Yun SI, Song BH, Frank JC, Julander JG, Olsen AL, Polejaeva IA, Davies CJ, White KL, Lee YM. Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection. Viruses. 10. PMID 30103523 DOI: 10.3390/V10080422  0.491
2018 Julander JG, Siddharthan V, Park AH, Preston E, Mathur P, Bertolio M, Wang H, Zukor K, Van Wettere AJ, Sinex DG, Morrey JD. Consequences of in utero exposure to Zika virus in offspring of AG129 mice. Scientific Reports. 8: 9384. PMID 29925850 DOI: 10.1038/S41598-018-27611-X  0.705
2018 Goz E, Tsalenchuck Y, Benaroya RO, Zafrir Z, Atar S, Altman T, Julander J, Tuller T. Generation and comparative genomics of synthetic dengue viruses. Bmc Bioinformatics. 19: 140. PMID 29745863 DOI: 10.1186/S12859-018-2132-3  0.45
2018 Magnani DM, Rogers TF, Maness NJ, Grubaugh ND, Beutler N, Bailey VK, Gonzalez-Nieto L, Gutman MJ, Pedreño-Lopez N, Kwal JM, Ricciardi MJ, Myers TA, Julander JG, Bohm RP, Gilbert MH, et al. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature Communications. 9: 1624. PMID 29691387 DOI: 10.1038/S41467-018-04056-4  0.549
2018 Zukor K, Wang H, Siddharthan V, Julander JG, Morrey JD. Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice. Journal of Neurovirology. PMID 29476408 DOI: 10.1007/S13365-017-0595-Z  0.606
2018 Clancy CS, Van Wettere AJ, Siddharthan V, Morrey JD, Julander JG. Comparative Histopathologic Lesions of the Male Reproductive Tract during Acute Infection of Zika Virus in AG129 and IFNAR-/- Mice. The American Journal of Pathology. PMID 29378173 DOI: 10.1016/J.Ajpath.2017.12.019  0.692
2017 Julander JG, Siddharthan V. Small-Animal Models of Zika Virus. The Journal of Infectious Diseases. 216: S919-S927. PMID 29267919 DOI: 10.1093/Infdis/Jix465  0.57
2017 Siddharthan V, Van Wettere AJ, Li R, Miao J, Wang Z, Morrey JD, Julander JG. Zika virus infection of adult and fetal STAT2 knock-out hamsters. Virology. 507: 89-95. PMID 28431283 DOI: 10.1016/J.Virol.2017.04.013  0.705
2017 Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 169: 176. PMID 28340344 DOI: 10.1016/J.Cell.2017.03.016  0.461
2017 Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. PMID 28222903 DOI: 10.1016/J.Cell.2017.02.017  0.441
2016 Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, Stewart J, Collins P, Gebre M, Neilson S, Van Wettere A, Lee YM, Sheridan WP, Morrey JD, Babu YS. Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Research. PMID 27838352 DOI: 10.1016/J.Antiviral.2016.11.003  0.755
2016 Guo F, Wu S, Julander J, Ma J, Zhang X, Kulp J, Cuconati A, Block TM, Du Y, Guo JT, Chang J. A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. Journal of Virology. PMID 27654301 DOI: 10.1128/Jvi.01253-16  0.534
2016 Yun SI, Song BH, Frank JC, Julander JG, Polejaeva IA, Davies CJ, White KL, Lee YM. Complete Genome Sequences of Three Historically Important, Spatiotemporally Distinct, and Genetically Divergent Strains of Zika Virus: MR-766, P6-740, and PRVABC-59. Genome Announcements. 4. PMID 27540058 DOI: 10.1128/Genomea.00800-16  0.308
2016 Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease. Journal of Infection and Public Health. PMID 27095300 DOI: 10.1016/J.Jiph.2016.04.002  0.595
2016 Julander JG. Animal models of yellow fever and their application in clinical research. Current Opinion in Virology. 18: 64-69. PMID 27093699 DOI: 10.1016/J.Coviro.2016.03.010  0.569
2014 Julander JG, Bantia S, Taubenheim BR, Minning DM, Kotian P, Morrey JD, Smee DF, Sheridan WP, Babu YS. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model. Antimicrobial Agents and Chemotherapy. 58: 6607-14. PMID 25155605 DOI: 10.1128/Aac.03368-14  0.666
2014 Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, ... Julander JG, et al. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. Plos Pathogens. 10: e1004213. PMID 24967809 DOI: 10.1371/Journal.Ppat.1004213  0.464
2014 Julander JG, Kesler K, Van Wettere AJ, Morrey JD, Smee DF. The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research. 108: 10-3. PMID 24837607 DOI: 10.1016/J.Antiviral.2014.05.002  0.696
2014 Dagley A, Ennis J, Turner JD, Rood KA, Van Wettere AJ, Gowen BB, Julander JG. Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Research. 108: 1-9. PMID 24833276 DOI: 10.1016/J.Antiviral.2014.05.004  0.616
2014 Julander JG, Thibodeaux BA, Morrey JD, Roehrig JT, Blair CD. Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model. Antiviral Research. 103: 32-8. PMID 24393669 DOI: 10.1016/J.Antiviral.2013.12.011  0.699
2014 Wu CC, Crain B, Yao S, Sabet M, Lao FS, Tawatao RI, Chan M, Smee DF, Julander JG, Cottam HB, Guiney DG, Corr M, Carson DA, Hayashi T. Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand. Journal of Innate Immunity. 6: 315-24. PMID 24192551 DOI: 10.1159/000355217  0.373
2013 Dagley A, Julander JG. A mouse model of chikungunya virus with utility in antiviral studies. Methods in Molecular Biology (Clifton, N.J.). 1030: 439-48. PMID 23821287 DOI: 10.1007/978-1-62703-484-5_33  0.561
2013 Wang H, Siddharthan V, Kesler KK, Hall JO, Motter NE, Julander JG, Morrey JD. Fatal neurological respiratory insufficiency is common among viral encephalitides. The Journal of Infectious Diseases. 208: 573-83. PMID 23641019 DOI: 10.1093/Infdis/Jit186  0.691
2013 Julander JG. Experimental therapies for yellow fever. Antiviral Research. 97: 169-79. PMID 23237991 DOI: 10.1016/J.Antiviral.2012.12.002  0.523
2013 Taylor JS, Zhang Q, Julander JG, Stoycheva AD, Tan H, Moy CV, Chanda S, Symons JA, Beigelman LN, Blatt LM, Hong J. 257 Cytokine. 63: 304. DOI: 10.1016/J.Cyto.2013.06.260  0.373
2012 Smee DF, Julander JG, Tarbet EB, Gross M, Nguyen J. Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents. Antiviral Research. 96: 13-20. PMID 22809862 DOI: 10.1016/J.Antiviral.2012.07.002  0.526
2012 Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. Plos One. 7: e31006. PMID 22292088 DOI: 10.1371/Journal.Pone.0031006  0.504
2011 Zasloff M, Adams AP, Beckerman B, Campbell A, Han Z, Luijten E, Meza I, Julander J, Mishra A, Qu W, Taylor JM, Weaver SC, Wong GC. Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proceedings of the National Academy of Sciences of the United States of America. 108: 15978-83. PMID 21930925 DOI: 10.1073/Pnas.1108558108  0.402
2011 Julander JG, Hagloch J, Latimer S, Motter N, Dagley A, Barnard DL, Smee DF, Morrey JD. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Research. 92: 228-36. PMID 21867731 DOI: 10.1016/J.Antiviral.2011.08.011  0.697
2011 Julander JG, Trent DW, Monath TP. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model. Vaccine. 29: 6008-16. PMID 21718741 DOI: 10.1016/J.Vaccine.2011.06.034  0.356
2011 Julander JG, Ennis J, Turner J, Morrey JD. Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrobial Agents and Chemotherapy. 55: 2067-73. PMID 21300837 DOI: 10.1128/Aac.01635-10  0.751
2011 Julander JG, Perry ST, Shresta S. Important advances in the field of anti-dengue virus research. Antiviral Chemistry & Chemotherapy. 21: 105-16. PMID 21233532 DOI: 10.3851/Imp1690  0.508
2011 Julander JG, Ennis J, Morrey J, Turner J. Effective Prophylactic and Therapeutic Treatment of Yellow Fever Virus with an Adenovirus-vectored Interferon, DEF201, in a Hamster Model Antiviral Research. 90: A34. DOI: 10.1016/J.Antiviral.2011.03.040  0.706
2011 Smee DF, Wong M, Tarbet EB, Julander J, Gross M, Nguyen J. Activities of Viral M2 Channel, Neuraminidase, and RNA Polymerase Inhibitors on Oseltamivir-Resistant H275Y Influenza A (H1N1) Virus Infections in Mice Antiviral Research. 90: A27. DOI: 10.1016/J.Antiviral.2011.03.019  0.514
2010 Gowen BB, Julander JG, London NR, Wong MH, Larson D, Morrey JD, Li DY, Bray M. Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virology Journal. 7: 240. PMID 20846417 DOI: 10.1186/1743-422X-7-240  0.651
2010 Lam AM, Murakami E, Espiritu C, Steuer HM, Niu C, Keilman M, Bao H, Zennou V, Bourne N, Julander JG, Morrey JD, Smee DF, Frick DN, Heck JA, Wang P, et al. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrobial Agents and Chemotherapy. 54: 3187-96. PMID 20516278 DOI: 10.1128/Aac.00399-10  0.616
2010 Monath TP, Lee CK, Julander JG, Brown A, Beasley DW, Watts DM, Hayman E, Guertin P, Makowiecki J, Crowell J, Levesque P, Bowick GC, Morin M, Fowler E, Trent DW. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine. 28: 3827-40. PMID 20347059 DOI: 10.1016/J.Vaccine.2010.03.023  0.305
2010 Julander JG, Jha AK, Choi JA, Jung KH, Smee DF, Morrey JD, Chu CK. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Research. 86: 261-7. PMID 20227442 DOI: 10.1016/J.Antiviral.2010.03.004  0.719
2010 Hong J, Taylor JS, Julander JG, Zhang Q, Stoycheva AD, Tan H, Moy CV, Chanda S, Beigelman LN, Blatt LM. PS2-39 Development of a hyperglycosylated IFN alfacon1 (CIFN): Towards once a month dosing for antiviral therapy Cytokine. 52: 58. DOI: 10.1016/J.Cyto.2010.07.244  0.312
2010 Julander J, Jha A, Choi J, Smee D, Morrey J, Chu C. Efficacy of 2′-C-Methylcytidine Against Yellow Fever Virus in a Hamster Model of Disease Antiviral Research. 86: A35-A36. DOI: 10.1016/J.Antiviral.2010.02.380  0.672
2009 Julander JG, Smee DF, Morrey JD, Furuta Y. Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Research. 82: 169-71. PMID 19428608 DOI: 10.1016/J.Antiviral.2009.02.201  0.721
2009 Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research. 82: 95-102. PMID 19428599 DOI: 10.1016/J.Antiviral.2009.02.198  0.727
2009 Nair V, Chi G, Shu Q, Julander J, Smee DF. A heterocyclic molecule with significant activity against dengue virus. Bioorganic & Medicinal Chemistry Letters. 19: 1425-7. PMID 19185487 DOI: 10.1016/J.Antiviral.2009.02.148  0.477
2009 Julander JG, Shafer K, Smee DF, Morrey JD, Furuta Y. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrobial Agents and Chemotherapy. 53: 202-9. PMID 18955536 DOI: 10.1128/Aac.01074-08  0.691
2009 Nair V, Chi G, Shu Q, Julander J, Smee D. A Heterocyclic Molecule with Significant Activity Against Dengue Virus Antiviral Research. 82: A62. DOI: 10.1016/j.antiviral.2009.02.148  0.377
2009 Julander J, Smee D, Morrey J, Furuta Y. Comparison of Various Combination Therapies for the Treatment of Yellow Fever Virus Antiviral Research. 82: A29. DOI: 10.1016/J.Antiviral.2009.02.049  0.672
2008 Julander JG, Bowen RA, Rao JR, Day C, Shafer K, Smee DF, Morrey JD, Chu CK. Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Research. 80: 309-15. PMID 18675850 DOI: 10.1016/J.Antiviral.2008.07.002  0.831
2008 Julander JG, Skirpstunas R, Siddharthan V, Shafer K, Hoopes JD, Smee DF, Morrey JD. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Research. 78: 230-41. PMID 18313150 DOI: 10.1016/J.Antiviral.2008.01.007  0.706
2008 Julander J, Shafer K, Smee D, Morrey J, Furuta Y. Efficacy of T-1106 or T-705, Alone or in Combination with Ribavirin, in the Treatment of Hamsters Infected with Yellow Fever Virus Antiviral Research. 78: A34. DOI: 10.1016/J.Antiviral.2008.01.060  0.666
2007 Selvam P, Vijayalakshimi P, Smee DF, Gowen BB, Julander JG, Day CW, Barnard DL. Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses. Antiviral Chemistry & Chemotherapy. 18: 301-5. PMID 18046963 DOI: 10.1177/095632020701800506  0.72
2007 Morrey JD, Siddharthan V, Olsen AL, Wang H, Julander JG, Hall JO, Li H, Nordstrom JL, Koenig S, Johnson S, Diamond MS. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Antimicrobial Agents and Chemotherapy. 51: 2396-402. PMID 17452485 DOI: 10.1128/Aac.00147-07  0.721
2007 Julander JG, Furuta Y, Shafer K, Sidwell RW. Activity of T-1106 in a hamster model of yellow Fever virus infection. Antimicrobial Agents and Chemotherapy. 51: 1962-6. PMID 17420215 DOI: 10.1128/Aac.01494-06  0.563
2007 Julander JG, Judge JW, Olsen AL, Rosenberg B, Schafer K, Sidwell RW. Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection. Antiviral Research. 75: 14-9. PMID 17210189 DOI: 10.1016/J.Antiviral.2006.11.005  0.551
2007 Julander JG, Siddharthan V, Blatt LM, Schafer K, Sidwell RW, Morrey JD. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology. 360: 454-60. PMID 17118420 DOI: 10.1016/J.Virol.2006.10.031  0.762
2007 Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Research. 73: 140-6. PMID 17049380 DOI: 10.1016/J.Antiviral.2006.08.008  0.725
2007 RAO J, JULANDER J, SIDWELL R, CHU C. Practical Synthesis of (−)-Carbocyclic Cytosine (Carbodine) and its In Vitro Antiviral Activity against Venezuelan Equine Encephalitis (VEE) Virus and Yellow Fever Virus Antiviral Research. 74: A47-A47. DOI: 10.1016/J.Antiviral.2007.01.057  0.529
2007 OLSEN A, MORREY J, JULANDER J, HALL J, SKIRPSTUNAS R, SIDWELL R. Lymphocytic Necrosis in Hamsters Inoculated with Western Equine Encephalitis Virus Antiviral Research. 74: A46-A46. DOI: 10.1016/J.Antiviral.2007.01.053  0.72
2007 JULANDER J, CHU C, RAO J, SHAFER K, MORREY J. Antiviral Activity of (−)-Carbocyclic Cytosine [(−)-Carbodine] Against Venezuelan Equine Encephalitis Virus (VEEV) in a Mouse Model Antiviral Research. 74: A44-A45. DOI: 10.1016/J.Antiviral.2007.01.050  0.645
2006 Julander JG, Winger QA, Rickords LF, Shi PY, Tilgner M, Binduga-Gajewska I, Sidwell RW, Morrey JD. West Nile virus infection of the placenta. Virology. 347: 175-82. PMID 16406457 DOI: 10.1016/J.Virol.2005.11.040  0.662
2005 Day CW, Smee DF, Julander JG, Yamshchikov VF, Sidwell RW, Morrey JD. Error-prone replication of West Nile virus caused by ribavirin. Antiviral Research. 67: 38-45. PMID 15919121 DOI: 10.1016/J.Antiviral.2005.04.002  0.788
2005 Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. Antiviral Research. 65: 79-85. PMID 15708634 DOI: 10.1016/J.Antiviral.2004.10.005  0.813
2004 Morrey JD, Day CW, Julander JG, Olsen AL, Sidwell RW, Cheney CD, Blatt LM. Modeling hamsters for evaluating West Nile virus therapies. Antiviral Research. 63: 41-50. PMID 15196819 DOI: 10.1016/J.Antiviral.2004.02.005  0.806
2004 Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chemistry & Chemotherapy. 15: 101-9. PMID 15185728 DOI: 10.1177/095632020401500202  0.794
2004 Iyer RP, Roland A, Jin Y, Mounir S, Korba B, Julander JG, Morrey JD. Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrobial Agents and Chemotherapy. 48: 2318-20. PMID 15155244 DOI: 10.1128/Aac.48.6.2318-2320.2004  0.651
2003 Julander JG, Colonno RJ, Sidwell RW, Morrey JD. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Research. 59: 155-61. PMID 12927305 DOI: 10.1016/S0166-3542(03)00109-8  0.667
2002 Julander JG, Sidwell RW, Morrey JD. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Research. 55: 27-40. PMID 12076749 DOI: 10.1016/S0166-3542(01)00223-6  0.679
Show low-probability matches.